Free Trial

The Biotech Growth Trust (LON:BIOG) Stock Crosses Above 200 Day Moving Average - What's Next?

The Biotech Growth Trust logo with Financial Services background

Key Points

  • The Biotech Growth Trust PLC shares have moved above their 200-day moving average, which currently stands at GBX 769.21 ($10.41), indicating a positive trend for the stock.
  • As of the latest trading session, the stock reached a high of GBX 954 ($12.91) and last traded at GBX 942 ($12.74) with a total volume of 181,498 shares.
  • The company focuses on capital appreciation through investments in the biotechnology industry, measuring performance against the NASDAQ Biotechnology Index.
  • Five stocks to consider instead of The Biotech Growth Trust.

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 769.21 ($10.43) and traded as high as GBX 954 ($12.94). The Biotech Growth Trust shares last traded at GBX 942 ($12.77), with a volume of 181,498 shares.

The Biotech Growth Trust Price Performance

The company's 50-day moving average price is GBX 844.67 and its two-hundred day moving average price is GBX 771.17. The company has a market cap of £218.20 million, a P/E ratio of -348.86 and a beta of 0.50. The company has a current ratio of 0.59, a quick ratio of 0.00 and a debt-to-equity ratio of 11.02.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

See Also

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.